Big Pharma market caps surge to start 2024 despite economic

The top 20 drugmakers — led by GLP-1 manufacturers Eli Lilly and Novo Nordisk — reported a total increase of 9.6% in market capitalization in the first quarter of 2024.

Related Keywords

Daiichi Sankyo , Ophelia Chan , Eli Lilly , Johnson , Pricewaterhousecoopers , Regeneron Pharmaceuticals , Drug Administration , Gilead Sciences , Novo Nordisk ,